"Poor-risk" germ cell tumors: current progress and future directions

Semin Oncol. 1992 Apr;19(2):206-14.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Biomarkers, Tumor / blood
  • Bleomycin / administration & dosage
  • Cisplatin / administration & dosage
  • Etoposide / administration & dosage
  • Neoplasms, Germ Cell and Embryonal / blood
  • Neoplasms, Germ Cell and Embryonal / drug therapy*
  • Prognosis
  • Risk Factors
  • Vinblastine / administration & dosage

Substances

  • Biomarkers, Tumor
  • Bleomycin
  • Vinblastine
  • Etoposide
  • Cisplatin

Supplementary concepts

  • BEP protocol
  • PVB protocol